Position in ALVO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$50,681
-$20,246 QoQ
Shares Held
14,776
+6.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. ALVO ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,509 | $747,034 |
All Filings in ALVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,681 | 14,776 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $70,927 | 13,826 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $91,326 | 11,151 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $131,512 | 13,600 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $167,213 | 12,639 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||